MVA Investors, LLC, 10% Owner at Eleven Biotherapeutics, Inc. (EBIO), sold 2,084,000 shares at $2.74 ($5.7M) on 2016-06-13, disclosed to the SEC on 2016-06-14.
Open-market sale of $5.7M EBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.74 | 177,140 | $485K | 8.5% |
| 2 | $2.74 | 177,140 | $485K | 8.5% |
| 3 | $2.74 | 864,860 | $2.4M | 41.5% |
| 4 | $2.74 | 864,860 | $2.4M | 41.5% |
| Total | $2.74 avg | 2,084,000 | $5.7M | 100% |
| Filing → |
| TNGX | SELL | 2024-05-03 | $1.6M | — | Filing → |
| TNGX | SELL | 2023-10-11 | $2.2M | — | Filing → |
| TNGX | BUY | 2023-08-15 | $2.4M | — | Filing → |